Conference
EARLY MOLECULAR RESPONSE PREDICTS ACHIEVEMENT OF UNDETECTABLE BCR-ABL IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) TREATED WITH NILOTINIB: 3-YEAR FOLLOW-UP OF ENESTCMR
Authors
Branford S; Kamel-Reid S; Bendit I; Etienne G; Guerci-Bresler A; Hughes TP; Lipton JH; Leber B; Spector N; Steegmann JL
Volume
99
Pagination
pp. 532-532
Publisher
FERRATA STORTI FOUNDATION
Publication Date
June 1, 2014
Name of conference
19th Congress of the European-Hematology-Association
Conference place
Milan, ITALY
Conference start date
June 12, 2014
Conference end date
June 15, 2014
Conference proceedings
HAEMATOLOGICA
ISSN
0390-6078